Monographie - Gemcitabine hydrochloride

Posledná aktualizácia :
29/10/2024

Gemcitabine hydrochloride

Chemický vzorec

Obchodný názov

Obchodné názvy sú orientačné, a zloženie pomocných látok sa môže líšiť v závislosti od krajiny a výrobcu.

Accogem	Mexiko
Antoril	Argentína
Axigem	Nemecko
Bendacitabin	Nemecko
Binoptos	Mexiko
Celzar	peru
Dercin	Rumunsko
Dhacibine	Malajzia
Emcitab	Kolumbia
Eriogem	Argentína, Ekvádor
Fotinex	Argentína, peru
Gebina	Argentína
Gebitan	Kolumbia
Gembio	Argentína, Čile, Ekvádor
Gemcimira	Čile, peru
Gemcit	Portugalsko
Gemcitabin	Nemecko
Gemcitac	Čile
Gemko	Turecko
Gemsibin	Turecko
Gemsol	Rakúsko
Gemtero	Čile, peru
Gemzar	Austrália, Belgicko, Brazília, Chorvátsko, Čile, Dánsko, Egypt, Ekvádor, Fínsko, Francúzsko, Grécko, Holandsko, Irán, Írsko, Island, Juhoafrická republika, Kanada, Kolumbia, Luxembursko, Maďarsko, Malajzia, Maroko, Mexiko, Nemecko, Nórsko, nový Zéland, Poľsko, Portugalsko, Rakúsko, Rumunsko, Slovinsko, Španielsko, Spojené arabské emiráty, Spojené štáty Americké, Švajčiarsko, Švédsko, Taliansko, Thajsko, Tunisko, Turecko, Veľká Británia, Venezuela
Gentabin	Kolumbia
Haxanit	Argentína, peru
Lenfotabin	Mexiko

Odkazy na literatúru : Gemcitabine hydrochloride

	Typ	Publikácia
1422	Časopis	Xu QA, Zhang Y, Trissel LA. Physical and chemical stability of gemcitabine hydrochloride solutions. J Am Pharm Assoc 1999 ; 39: 509-513.
1423	Časopis	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1501	Časopis	Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M. Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials. Int J Pharm 1999 ; 185: 113-121.
1520	Laboratórium	Etude de stabilité des médicaments en Ecoflac® B Braun 2001
1611	Časopis	Chalmers JR, Bobek MB, Militello MA. Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs. Am J Health-Syst Pharm 2001 ; 58: 504-506.
1625	Časopis	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1662	Časopis	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1663	Časopis	Ponton JL, Munoz C, Rey M, Val M. The stability of (lyophilized) gemcitabine in 0.9% sodium chloride injection. EJHP 2002 ; 1: 23-25.
1925	Časopis	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
1953	Časopis	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982	Časopis	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2009	Časopis	Trissel LA, Zhang Y. Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration. Int J Pharm Compound 2005 ; 2005, 9, 4: 320-322.
2262	Časopis	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2344	Laboratórium	Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution. Ebewe Pharma 2009
3262	Časopis	Manners S, Galettis P, de Souza P. Conditions causing gemcitabine crystallization. J Oncol Pharm Practice 2011 ; 17, 4: 395-399.
3496	Laboratórium	Gemcitabin Actavis solution - Stability Study Actavis 2009
3670	Časopis	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
4310	Časopis	Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hiral M. Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs. Kaohsiung J Med Sci 2017 ; 63, 1: E9-E16.
4736	Časopis	Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L. An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions. J Pharm Biomed Anal 2023

Mentions Légales